SCHEMBL4734027

SCHEMBL4734027

CNC1CCC(Cc2cc(-c3ccc(C(C)=O)cc3)ccc2F)(NC(=O)C(F)(F)F)CC1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.39
HSD17B1 P14061 1/20 0.36
BDKRB1 P46663 4/20 0.32
CNR1 P21554 1/20 0.32
PKM P14618 1/20 0.32
MELK Q14680 1/20 0.32
SYK P43405 1/20 0.31
MMP12 P39900 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GNRHR P30968 1/20 0.30
TAS1R3 Q7RTX0 1/20 0.30
TAS1R1 Q7RTX1 1/20 0.30
TAS1R2 Q8TE23 1/20 0.30
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735928 0.92 BDKRB1 (0.35) KIF11BDKRB1CNR1TAS1R3TAS1R1
SCHEMBL4730292 0.90 BDKRB1 (0.35) BDKRB1CNR1MELK
SCHEMBL4728846 0.90 TACR1 (0.36) BDKRB1CNR1
SCHEMBL4731672 0.90 NPC1 (0.33) BDKRB1CNR1GNRHR
SCHEMBL4731467 0.89 TRPA1 (0.36) KIF11BDKRB1CNR1MEN1KMT2A
SCHEMBL4734018 0.89 PDK2 (0.37) BDKRB1CNR1SYKMEN1KMT2A
SCHEMBL4735935 0.88 MTNR1B (0.38) BDKRB1CNR1MEN1KMT2A
SCHEMBL4733618 0.87 MAPT (0.39) BDKRB1CNR1MELK
SCHEMBL4733336 0.87 MCHR1 (0.36) KIF11
SCHEMBL4734146 0.86 BDKRB1 (0.31) BDKRB1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120245184-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION ADERANS RESEARCH INSTITUTE, INC. 2012-09-27 US disclosed
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057469-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION WYETH (US) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO KIF11 3464/4885HSD17B1 3087/4885BDKRB1 3686/4885
US-20120245184-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION GLI1, SHH, SMO KIF11 3464/4885HSD17B1 3087/4885BDKRB1 3686/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO KIF11 3464/4885HSD17B1 3087/4885BDKRB1 3686/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO KIF11 3556/4885HSD17B1 2356/4885BDKRB1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.